The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting the efficacy of nivolumab combined with radiation therapy by longitudinal liquid biopsy with artificial intelligence for patients with metastatic breast cancer (translational research of the KBCRN-B-002 trial).
 
Kosuke Kawaguchi
No Relationships to Disclose
 
Masahiro Takada
Speakers' Bureau - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kiowa Kirin; Lilly; Pfizer
Research Funding - AstraZeneca; Eisai
 
Takeshi Kotake
No Relationships to Disclose
 
Michio Yoshimura
No Relationships to Disclose
 
Ryuji Uozumi
Consulting or Advisory Role - CAC Croit Corporation; Eisai
 
Masako Kataoka
No Relationships to Disclose
 
Takahiko Koyama
No Relationships to Disclose
 
Reitaro Tokumasu
No Relationships to Disclose
 
Hironori Kato
No Relationships to Disclose
 
Hiroshi Yoshibayashi
No Relationships to Disclose
 
Hirofumi Suwa
No Relationships to Disclose
 
Wakako Tsuji
No Relationships to Disclose
 
Hiroyasu Yamashiro
Speakers' Bureau - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kiowa Kirin; Pfizer
 
Tatsuki R Kataoka
No Relationships to Disclose
 
Hiroshi Ishiguro
No Relationships to Disclose
 
Laxmi Parida
No Relationships to Disclose
 
Satoshi Morita
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Lilly; MSD; Pfizer; Taiho Pharmaceutical
 
Masakazu Toi
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Genomic Health; Konica Minolta; Kyowa Hakko Kirin; Lilly; Novartis; Pfizer; Shimadzu; Taiho Pharmaceutical; TAKEDA; Yakult Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; Konica Minolta; Kyowa Hakko Kirin
Speakers' Bureau - AstraZeneca; Lilly; Pfizer
Research Funding - AFI technology; Astellas Pharma; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Japan Breast Cancer Research Group; Kyoto Breast cancer Research Network; Nippon Kayaku; Ono Pharmaceutical; Pfizer; Shimadzu; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - JP 2017-143763 WO2017/131162A1 (Inst); PCT/JP2016/004374 (Inst)
Travel, Accommodations, Expenses - Eisai; Takeda
Other Relationship - Japan Breast Cancer Research Group; Japan Breast Cancer Research Group; Kyoto Breast Cancer Research Network; Organization for Oncology and Translational Research